"The unprecedented expansion of our global network will continue to support improvements to local cancer patients’ care and novel multinational research.”. Learn more about the expansion of @flatironhealth's research network in last week’s press release:

🎥 Go behind the research with Aaron Cohen on our latest research presented at #AACRai25 that showed LLMs can match expert human abstractors in extracting nuanced cancer progression events from EHRs—across 14 tumor types. Watch now:

In the latest episode of the @HealthTechRmdy, our GM of Clinical Research, Alex Deyle, shares how Flatiron is building a reusable research infrastructure—not just for one study, but for the future of oncology trials. 🎧 Listen here:

ANNOUNCED TODAY: @flatironhealth has tripled the size of our international oncology research network across the UK, Germany, and Japan—unlocking new possibilities for global research and #RWE. Learn more about how we’re transforming cancer care globally:

TOMORROW! Hear from site engagement experts at @Sanofi and @flatironhealth as they share how to overcome common challenges in clinical trial tech implementation with EHR-to-EDC technology ⤵️.

Eri Tajima recently presented at the 38th Anti-Tumor Drug Development Forum in Japan⬇️. The session spoke to global trends in #RWE + how high-quality #RWD is advancing oncology research and clinical decision-making around the world. Learn more:

The FORUM research consortium, powered by Flatiron + in partnership w @Gilead, @Pfizer, @EUdaiichisankyo, & @Roche, is publishing benchmarking studies comparing outcomes for patients in different countries, using #RWD + rigorous adjustment. Learn more:

🎥 Go behind the research in this exclusive video and learn the motivation, methodology, & impact of our AACR AI study—highlighting how LLMs and the VALID framework are transforming the extraction of critical progression data from EHRs. Watch now:

Hear from site engagement leaders at Sanofi and Flatiron as they share to overcome common challenges in implementing EHR-to-EDC tech at the site level. Wednesday 7/23 at 12 PM: .

NEW TODAY: Our latest study presented at #AACRai25 demonstrates how #LLMs can accurately and efficiently extract real-world cancer progression events from unstructured EHR data across 14 cancer types. Read the full press release:

We’re setting a new standard for responsible AI in oncology by embedding fairness, transparency, and equity into every step of our model development. 👉 Read Cleo Ryals' new blog today:

Hear from site engagement experts at @Sanofi and @flatironhealth as they share how to overcome common challenges in clinical trial tech implementation, and specifically how sites and sponsors can work together to implement EHR to EDC technology.

Flatiron's Arun Sujenthiran presented @ the 2nd Pfizer Oncology Symposium: Breast Cancer JOIN 2025 in Fukuoka, JP that brought together over 230 breast cancer physicians to discuss advances in treatment & care. Learn more about how we use RWE in Japan:

Recent research provides important #RWE on the effectiveness of immunotherapy combined with chemotherapy for patients with resectable NSCLC, however, the findings highlight that significant gaps in their adoption. Click for more on why this matters:

ANNOUNCED TODAY: Flatiron Health has integrated Adaptive Biotechnologies’ clonoSEQ® MRD test into OncoEMR®. Learn more:

We’re bringing together top voices in oncology #RWE for an upcoming @Financial Times webinar. Don’t miss their insights on the evolving landscape of real-world evidence in Europe. Register now:

The @flatironhealth team is excited to attend the @AACI_Cancer's Clinical Research Innovation meeting this June!. Don’t miss our session on Mon 6/23 at 4:30 PM, “Bridging Innovation and Implementation: Recent Advances and Real-World Lessons on Clinical Trial Technology.”.

Hear from Flatiron’s Erin Fidyk on the largest real-world study of ctDNA in early-stage breast cancer: ctDNA+ is linked to higher recurrence & worse outcomes across all subtypes. See #ASCO25 findings on how #RWD is shaping personalized care. 🔗

The @flatironhealth team is excited to attend the @AACI_Cancer's Clinical Research Innovation meeting this June!. Don’t miss our session on 6/24 at 12:30 PM, “Bridging Innovation and Implementation: Recent Advances and Real-World Lessons on Clinical Trial Technology.”.

Dive into how we’re using advanced machine learning to extract rich insights from NGS reports—turning a “geyser” of genetic data into actionable real-world evidence for cancer research. Read more: